A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
Confusion over US tarifs
Switzerland is weighing its response after the US Supreme Court struck down much of Donald Trump’s tariff regime.
Possible new Iranian meeting in Geneva this week
The Iranian foreign minister says there could be a new meeting with the American delegation in Geneva to discuss their nuclear program.
Driver tackles tunnel fire in Geneva
A young man is being praised for his bravery after he tackled a fire in the Vernier tunnel on the A1 just outside Geneva on Friday afternoon.
Avalanche claims another life
A 22-year-old skier has died in an avalanche in Verbier.
Now hairdressers charge for no-shows
No-shows are becoming an escalating problem for Swiss businesses.
Cat cancer may help humans
Researchers at the University of Bern say genetic changes in cat tumours closely mirror those seen in human breast cancer - a discovery that could open new paths for treatment.
